Chinese AI Lab Automation Startup MegaRobo Secures $200M from Oman Sovereign Wealth Fund

Chinese AI and robotics company MegaRobo Technologies secured nearly 200 million dollars in fresh funding on November 19 2026.
The round attracted participation from Oman Investment Authority alongside CMB International and prior backers.
Strategic Capital Signals Deeper Global Ties
This investment highlights how sovereign wealth funds from the Middle East are increasingly backing Chinese deep tech firms in artificial intelligence.
Founders in emerging markets can learn from MegaRobo pattern of combining lab automation tools with AI to speed up scientific experiments.
Pharma companies stand to gain faster drug pipelines while traditional lab equipment makers may lose ground to automated solutions.
The company has now raised approximately 600 million dollars in total since its founding about ten years ago.
Twelve Month Outlook for AI in Science
Over the next year MegaRobo plans to expand its AI for Science offerings into more regions including Europe and North America.
Continued capital inflows into similar startups suggest the sector could see more consolidation or additional large rounds.
Founders should watch for how such infrastructure enables AI models to handle complex physical tasks beyond software alone.
Historical patterns show post pandemic interest in biotech automation has sustained investor appetite despite broader market shifts.
This deal underscores the value of patient capital from diverse sources for scaling hardware intensive AI ventures.








